Local News: Mesilla, NM 

 | 

Sign Up

 | 

Sign In

Pharmaceuticals

Forum & Polls

News

Email me Pharmaceuticals news. Learn more

5 hrs ago | The News Tribune

CareFusion profit drops in 2Q after spinoff

Cardinal Health Inc. said Thursday its profit fell 26 percent in the fiscal second quarter after it spun off its medical technology business, but the drug distributor boosted its full-year profit guidance, sending it shares to a new high.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cardinal Health, Management, 9, Telecom, ADC Telecommunications, Semiconductors, RF Micro Devices, Electronics

13 hrs ago | Investor's Business Daily

Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration issued a complete response letter regarding the new drug application for Zuplenz oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.

Comment?

Related Topix: Food and Drug Administration, Nausea, Medicine, Vomiting, Health, Biotech, Healthcare Industry, Pharmaceutical Resources

Mon Feb 08, 2010

International Business Times

CVS Caremark profit tops view; shares jump

CVS Caremark Corp said recent problems at its pharmacy benefits management unit have been corrected and it posted a slightly better-than-expected rise in quarterly profit as its drugstore bested its rivals, driving the company's shares up as much as 8.8 percent.

Comment?

Related Topix: Biotech, Retail, Medicine, Caremark Rx, Healthcare Industry

Philadelphia Business Journal

Teva gets Nordic, Baltic rights for drug

Teva Pharmaceutical Industries Ltd. and Active Biotech amended their marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Marketing

ABC News - Brian Ross

CVS Caremark Quarterly Profit, Sales Climb

Earnings rose to $1.05 billion, or 74 cents per share, in the fourth quarter from $949 million, or 65 cents per share, a year earlier.

Comment?

Related Topix: Caremark Rx, Biotech, Retail, Medicine, Healthcare Industry

Sun Feb 07, 2010

Miami Herald

Perrigo 2Q profit doubles without write-down

Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its other drugs held steady.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Anemia, Health, Citrix Systems, Software, Computers, Cardinal Health, Hologic, Medical Equipment

Sat Feb 06, 2010

Myrtle Beach Online

Northrop posts 4Q profit on higher sales

Defense contractor Northrop Grumman Corp. said Thursday it posted a fourth-quarter profit of $413 million in contrast to a year-ago loss as sales rose 2 percent.

Comment?

Related Topix: Manufacturing, Northrop Grumman, Aerospace-Defense, 9, Biotech, Medicine, Healthcare Industry, Cardinal Health, Hotels, Starwood Hotel and Resorts Worldwide, Travel/Tourism, Industrial Machines, Eaton, Ashland, Oil & Gas, Chemicals

Fri Feb 05, 2010

SignOnSanDiego.com

Earnings Preview: CVS Caremark to report 4Q

Friday, February 5, 2010 at 7:46 a.m. WOONSOCKET, R.I. - Drugstore operator and pharmacy benefits manager CVS Caremark Corp.

Comment?

Related Topix: Caremark Rx, Biotech, Retail, Medicine, Healthcare Industry, Woonsocket, RI

ABC News - Brian Ross

Teva Pharma Settles Some Medicaid Drug Price Suits

Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Friday it is settling several lawsuits related to Medicaid reimbursement for its products, and is setting aside $315 million to cover the settlement and other suits.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry

Thu Feb 04, 2010

Business Wire India

Biocon and Bayer Join Hands to Create Awareness for Self Monitoring in Diabetics

Bangalore, Karnataka, India, Thursday, February 04, 2010 -- Biocon and Bayer Healthcare, a subsidiary of Bayer AG, one of the worldA's leading, innovative companies in the healthcare and medical products industry; have entered into a strategic partnership to fight the diabetes menace in India.

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, World News, India, Medicine, Diabetes, Health, Marketing

Wed Feb 03, 2010

The Hartford Courant

Achillion's New Shares Raise $22.9M

Achillion Pharmaceuticals Inc. said Tuesday that it has raised $22.9 million from its recent sale of additional shares of common stock.

Comment?

Related Topix: Achillion Pharmaceuticals

Drugs.com

Teva Announces FDA Accepts BLA for XM02

Feb 2, 2010 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for filing Teva's Biologics License Application for XM02, a granulocyte colony-stimulating factor for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with ...

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Food and Drug Administration, Medicine, Healthcare Industry, Neupogen, Filgrastim (generic), Medication, Marketing

Tue Feb 02, 2010

Panolian

Arrest Log 02-02-10

Tuesday, February 02, 2010 Panola County Arrest Log 02-02-10 The following information was taken from the log book at the David M. Bryan Justice Complex.

Comment?

Related Topix: Batesville, MS, Panola County, MS, Pope, MS, Courtland, MS, Biotech, D and K Healthcare Resources, Medicine, Healthcare Industry

Drug Store News

Watson to become commercial partner for emergency contraceptive

MORRISTOWN,A N.J. Watson Pharmaceuticals and HRA Pharma have signed a deal whereby Watson will become the commercial partner for an emergency contraceptive undergoing regulatory review by the Food and Drug Administration, Watson announced Monday.

Comment?

Related Topix: Biotech, Watson Pharmaceuticals, Medicine, Healthcare Industry

Columbus Dispatch

Cardinal closing ends jobs for 115

Cardinal Health plans to close its Findlay, Ohio, distribution center in April, a move that will put about 115 employees out of work, the company said yesterday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cardinal Health, Findlay, OH, Wheeling, WV Metro

Mon Feb 01, 2010

American Chronicle

News and FDA Updates for Gilead

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Keryx Biopharmaceuticals, Mylan Laboratories, Opinion

Sun Jan 31, 2010

Drugs.com

Bayer to Discontinue Phase II Clinical Trial for Long-Acting...

Bayer Schering Pharma AG, Germany has announced that an independent Data Safety and Monitoring Board has completed an interim analysis of a phase II trial of the company's long-acting recombinant factor VIII, BAY79-4980. The DSMB concluded that the study will not be able to achieve the predetermined efficacy endpoint .

Comment?

Related Topix: Manufacturing, Bayer AG, Biotech, Chemicals, Bayer Schering Pharma AG, Hemophilia, Health, Medicine, Kogenate, Antihemophilic Factor (generic), Medication

Sat Jan 30, 2010

Myrtle Beach Online

Time Warner Cable posts profit but outlook low

Time Warner Cable Inc. reported a profit for the fourth quarter Thursday but the economy was still weighing on its customers, who cut back on their subscriptions of premium movie channels and ordered fewer videos on demand.

Comment?

Related Topix: Cable & Satellite, Telecom, Comcast, Citrix Systems, Software, 9, Biotech, Medicine, Healthcare Industry, Cardinal Health, Business News

Fri Jan 29, 2010

The Chronicle-Journal

Thompson Creek expects net loss for 2009 due to change in accounting measures

Molybdenum producer Thompson Creek Metals says its previously announced switch to U.S. accounting principles will require a different treatment for the warrants it has issued and that will result in a net loss for fiscal 2009.

Comment?

Related Topix: Tongjitang Chinese Medicines

Business First-Columbus

Cardinal Health ups post-spinoff outlook

The absence of Cardinal Health Inc. 's CareFusion Corp. spinoff drove the health-care giant's fiscal second-quarter earnings down, but the company is raising its full-year outlook after closing the books on the first half of the year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cardinal Health

Make your opinion count!

Don't hold it in. Give us your opinion and let it out. Take surveys. You could win $5,000.
Plus earn points for every survey completed!

Pharmaceuticals Jobs

Also on Topix